Pfizer (PFE) Tops Q2 EPS by 21c, Beats on Revenue; Offers FY25 EPS Guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $24.52 +2.68%
EPS Growth %: -12.8%
Financial Fact:
Discontinued operations--net of tax: 0
Today's EPS Names:
PKE, LNN, More
EPS Growth %: -12.8%
Financial Fact:
Discontinued operations--net of tax: 0
Today's EPS Names:
PKE, LNN, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q2 EPS of $0.78, $0.21 better than the analyst estimate of $0.57. Revenue for the quarter came in at $14.7 billion versus the consensus estimate of $13.47 billion.
GUIDANCE:
Pfizer sees FY2025 EPS of $2.90-$3.10, versus the consensus of $3.01.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX (SPCX) call put ratio 2 calls to 1 put as share price at $160
- NorthStar Announces Appointment of Successor Auditor
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
